Clinical Trial Report

Pyrotinib Plus Trastuzumab as an Effective Later-Line Therapeutic Strategy for HER2-Positive Metastatic Colorectal Cancer: Results from a Phase II Study

Yang W, Zhang J, Wu G, Zhang W, Zhou A, Yang L, Sun Y

Drug Design, Development and Therapy 2025, 19:10269-10280

Published Date: 21 November 2025